FDA Approves Amgen ' s Biosimilar to J & J ' s Rheumatoid Arthritis Drug FDA Approves Amgen ' s Biosimilar to J & J ' s Rheumatoid Arthritis Drug

The U.S. Food and Drug Administration on Friday approved Amgen Inc ' s biosimilar copy of Johnson& Johnson ' s blockbuster rheumatoid arthritis drug, Remicade, according to the regulator ' s website.Reuters Health Information
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Pharmacist News Source Type: news